Medical Technology Systems MSYS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medical Technology Systems MSYS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DJ Clancey who wrote (122)	6/9/1998 2:07:00 AM
From: Dave B	of 139

A couple of areas of interest going forward when results are released. 1)Are Selling, General, and Administrative(SG&A) expenses going to decrease as a percentage of sales. This number has been up dramatically over the past year...are revenues going to begin showing a return for this increased investment??? 2)Is the drug lab division still going to show strong growth, if so this will become a very strong asset going forward. As it does not fit into the core business directly it could be either sold to strengthen balance sheet or continue to contribute to the bottom line. This company has plenty of positives going for it...it's time to move to the next level. Sales are up over last year, while the stock price is down. PR...PR...PR---Where is it???? Any thoughts???? D.B.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next